Carolina Wealth Advisors LLC purchased a new stake in The Clorox Company (NYSE:CLX – Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 295 shares of the company’s stock, valued at approximately $48,000.
Other institutional investors and hedge funds have also modified their holdings of the company. Northwest Investment Counselors LLC grew its stake in shares of Clorox by 1.8% during the third quarter. Northwest Investment Counselors LLC now owns 5,743 shares of the company’s stock worth $936,000 after purchasing an additional 100 shares during the period. Retirement Guys Formula LLC boosted its position in shares of Clorox by 7.6% in the third quarter. Retirement Guys Formula LLC now owns 5,061 shares of the company’s stock valued at $825,000 after acquiring an additional 356 shares during the period. Toth Financial Advisory Corp lifted its holdings in shares of Clorox by 5.4% during the 3rd quarter. Toth Financial Advisory Corp now owns 11,103 shares of the company’s stock worth $1,809,000 after acquiring an additional 567 shares during the period. Vest Financial LLC lifted its stake in Clorox by 20.0% in the 3rd quarter. Vest Financial LLC now owns 362,047 shares of the company’s stock valued at $58,981,000 after purchasing an additional 60,306 shares during the last quarter. Finally, Stegent Equity Advisors Inc. grew its stake in shares of Clorox by 29.8% in the third quarter. Stegent Equity Advisors Inc. now owns 2,123 shares of the company’s stock worth $346,000 after purchasing an additional 487 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
A number of equities research analysts recently weighed in on CLX shares. BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a report on Friday, September 6th. Citigroup upped their price objective on shares of Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. Deutsche Bank Aktiengesellschaft upped their target price on Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Evercore ISI reduced their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research note on Monday, October 14th. Finally, Wells Fargo & Company decreased their price target on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a research report on Wednesday, July 10th. Six investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat.com, Clorox has a consensus rating of “Hold” and a consensus price target of $150.14.
Clorox Trading Down 0.7 %
NYSE:CLX traded down $1.09 on Monday, reaching $160.87. The company’s stock had a trading volume of 347,014 shares, compared to its average volume of 1,226,290. The firm has a market cap of $19.98 billion, a price-to-earnings ratio of 83.92, a price-to-earnings-growth ratio of 3.19 and a beta of 0.41. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The Clorox Company has a 12-month low of $114.68 and a 12-month high of $169.09. The stock has a 50 day moving average price of $159.28 and a 200 day moving average price of $145.14.
Clorox (NYSE:CLX – Get Free Report) last announced its earnings results on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.28. The company had revenue of $1.90 billion during the quarter, compared to analyst estimates of $1.97 billion. Clorox had a net margin of 3.95% and a return on equity of 281.12%. On average, equities analysts anticipate that The Clorox Company will post 6.64 EPS for the current fiscal year.
Clorox Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be given a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.03%. The ex-dividend date is Wednesday, October 23rd. Clorox’s payout ratio is 252.85%.
Insiders Place Their Bets
In other news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.51% of the stock is owned by insiders.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
- Five stocks we like better than Clorox
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Analysts Predict New Highs for Cybersecurity Stock by Christmas
- What is a Bond Market Holiday? How to Invest and Trade
- Nuclear Power Reaches Critical Mass: Top Stocks to Watch Now
- What is the NASDAQ Stock Exchange?
- 2 Energy Stocks Surging on Billion-Dollar DOE Loan Commitments
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.